Anna Helbok
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 8
- Peptidase Inhibition and Analysis 7
-
- Radiopharmaceutical Chemistry and Applications 6
- Medical Imaging Techniques and Applications 3
- Co-authors
- Clemens Decristoforo (13 shared papers)Hubertus Haas (4 shared papers)Miloš Petřík (4 shared papers)Michael Blatzer (3 shared papers)Cornelia Lass‐Flörl (3 shared papers)Elisabeth von Guggenberg (9 shared papers)Markus Schrettl (3 shared papers)Christine Rangger (6 shared papers)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (3 papers)Nuclear Medicine and Biology (3 papers)Histochemistry and Cell Biology (2 papers)Journal of Nuclear Medicine (1 paper)European Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- AustriaUnited KingdomTürkiye
In The Last Decade
Anna Helbok
16 papers receiving 595 citations
Peers
Comparison fields: 5 of 75
- Radiology, Nuclear Medicine and Imaging 221
- Biomaterials 94
- Infectious Diseases 121
- Oncology 155
- Molecular Medicine 28
Countries citing papers authored by Anna Helbok
This map shows the geographic impact of Anna Helbok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Helbok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Helbok more than expected).
Fields of papers citing papers by Anna Helbok
This network shows the impact of papers produced by Anna Helbok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Helbok. The network helps show where Anna Helbok may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Helbok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 108 | |
| 2 | 2012 | 99 | |
| 3 | 2011 | 77 | |
| 4 | 2011 | 68 | |
| 5 | 2009 | 58 | |
| 6 | 2009 | 39 | |
| 7 | 2013 | 36 | |
| 8 | 2013 | 32 | |
| 9 | 2011 | 28 | |
| 10 | 2010 | 16 | |
| 11 | 2010 | 16 | |
| 12 | 2019 | 10 | |
| 13 | 2020 | 6 | |
| 14 | 2009 | 5 | |
| 15 | Design and evaluation of novel radiolabelled VIP derivatives for tumour targeting. | 2013 | 3 |
| 16 | 2010 | 3 |
About Anna Helbok
Anna Helbok is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Epidemiology and Biomaterials, having authored 16 papers that have together received 604 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Nanoparticle-Based Drug Delivery (5 papers), Medical Imaging Techniques and Applications (3 papers), Antifungal resistance and susceptibility (3 papers), RNA Interference and Gene Delivery (3 papers), Neuroendocrine Tumor Research Advances (3 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (221 citations), Biomaterials (94 citations), Infectious Diseases (121 citations), Oncology (155 citations) and Molecular Medicine (28 citations). Anna Helbok has collaborated with scholars based in Austria, United Kingdom and Türkiye. Frequent co-authors include Clemens Decristoforo, Hubertus Haas, Miloš Petřík, Michael Blatzer, Cornelia Lass‐Flörl, Elisabeth von Guggenberg, Markus Schrettl, Christine Rangger, Georg Dobrozemsky and Hermann Dietrich. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Nuclear Medicine and Biology, Histochemistry and Cell Biology, Journal of Nuclear Medicine and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.